A2A Pharmaceuticals, Inc. - 31 Mar 2023 Form 4/A - Amendment Insider Report for Biomea Fusion, Inc. (BMEA)

Role
10%+ Owner
Signature
Edward Painter
Issuer symbol
BMEA
Transactions as of
31 Mar 2023
Net transactions value
-$6,250,000
Form type
4/A - Amendment
Filing time
06 Apr 2023, 19:31:22 UTC
Date Of Original Report
31 Mar 2023
Previous filing
19 Aug 2022
Next filing
26 Apr 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BMEA Common Stock Sale $6,250,000 -200,000 -4.7% $31.25 4,100,000 31 Mar 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 A total of 200,000 shares were sold at an average price of 31.25 in multiple transactions ranging in price from 30.87 to 31.64. Additional details of the individual transactions are available upon request.